Evidence map›Paper›PMID 41900114›Full record

ReviewMolecules (Basel, Switzerland)2026

Herbal Textual Research, Phytochemistry, Pharmacology and Toxicity of Atractylodis Rhizoma: A Comprehensive Review.

Jin Sun, Juhui Qiao, Jian Tang, Nuo Cheng, Miaomiao Gao, Jingrong Yang, Baixin Kou

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jin SunSchool of Chinese Medicine, Bozhou University, Bozhou 236800, China.ORCID 0000-0001-7595-3621
Juhui QiaoSchool of Chinese Medicine, Bozhou University, Bozhou 236800, China.
Jian TangSchool of Chinese Medicine, Bozhou University, Bozhou 236800, China.ORCID 0000-0003-3289-3352
Nuo ChengSchool of Chinese Medicine, Bozhou University, Bozhou 236800, China.
Miaomiao GaoSchool of Chinese Medicine, Bozhou University, Bozhou 236800, China.
Jingrong YangSchool of Medicine, Changchun Sci-Tech University, Changchun 130600, China.
Baixin KouSchool of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China.

Funding

Anhui Provincial College Student Innovation and Entrepreneurship Training Program S202512926013Bozhou University Research Start-up Project BYKQ202536National Natural Science Foundation of China 82504995
6 · The paper itself

Abstract

This review examines the historical development, ethnopharmacology, traditional applications, phytochemistry, and pharmacological attributes of Atractylodis Rhizoma (AR). Data were collected from a range of electronic databases, academic libraries, and classical literature. In China, AR is highly valued for its medicinal properties. Research has identified 327 compounds, including sesquiterpenes, triterpenes, flavonoids, and phenolics, which contribute to its diverse pharmacological activities, such as antimicrobial, anti-inflammatory, antioxidant, hepatoprotective, and neuroprotective effects. AR is particularly effective in treating modern gastrointestinal disorders and influenza. As a traditional herb with a rich historical background, AR exhibits significant therapeutic potential. This review aims to correlate its active components with its primary therapeutic effects and highlight existing research gaps. Current studies primarily focus on extraction methods and pharmacodynamics. Future research should employ multi-omics and molecular biology techniques to further elucidate active components and their targets, while also addressing the challenge of low bioavailability.

Indexed as

AtractylodesPhytochemicalsPlant ExtractsRhizomeAnimalsEthnopharmacologyHumansPhytochemicalsPlant ExtractsAtractylodes chinensisAtractylodes lanceaatractylodinethnopharmacology

Identifiers

PMID41900114
PMCPMC13029298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.